Oblastni nemocnice Mlada Boleslav a.s. nemocnice Stredoceskeho kraje
- Address
- Trida Vaclava Klementa 147, 293 01 Mladá Boleslav, Czechia
Oblastni nemocnice Mlada Boleslav - Regional Hospital of Central Bohemia
Oblastni nemocnice Mlada Boleslav is a prominent regional hospital in the Central Bohemian region of the Czech Republic, demonstrating significant expertise in respiratory medicine and ophthalmology. The center actively participates in advanced clinical trials evaluating novel therapeutic approaches for chronic respiratory conditions and retinal diseases, contributing valuable data to international research efforts.
- Chronic Obstructive Pulmonary Disease (COPD) treatment optimization, including studies of triple therapy combinations and novel add-on medications
- Severe and uncontrolled asthma management, evaluating advanced inhaler formulations and biologic therapies
- Diabetic Macular Edema and Age-Related Macular Degeneration, investigating innovative intravitreal delivery systems
- Acute and chronic conditions including viral lung infections, liver cirrhosis, and deep vein thrombosis
The hospital's research portfolio reflects a comprehensive approach to patient care, with particular strength in evaluating maintenance therapies for chronic respiratory diseases and anti-VEGF therapies for retinal pathologies. The center's participation in multi-phase clinical trials demonstrates its capacity to conduct complex research protocols while maintaining high standards of patient safety and data quality in accordance with international clinical research guidelines.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1AstraZeneca AB1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB3trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Oblastni nemocnice Mlada Boleslav a.s. nemocnice Stredoceskeho kraje
lock Showing 1 of 13 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double‑Blind, Placebo‑Controlled Phase 2/3 Study of Subcutaneous PF‑07275315 in Adults with Moderate‑to‑Severe Chronic Obstructive Pulmonary Disease | Pfizer Inc. | Phase II | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 18 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorescein Sodium | 3 | Unknown | 2024-11-22 | 2026-06-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.